Vera Therapeutics (VERA) Long-Term Investments (2021 - 2023)
Vera Therapeutics (VERA) posted Long-Term Investments of $11000.0 for Q4 2023, down 15.38% on a QoQ basis from $13000.0 in Q3 2023, and down 81.03% year-over-year from $58000.0 in Q4 2022.
Vera Therapeutics (VERA) Long-Term Investments (2021 - 2023) Analysis & Trends
Vera Therapeutics' Long-Term Investments history runs 3 years deep, the most recent figure standing at $11000.0 for Q4 2023.
- Quarterly Long-Term Investments fell 81.03% year-over-year to $11000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $11000.0 (down 81.03% YoY) and the FY2023 annual result came in at $11000.0, down 81.03% from the prior year.
- Long-Term Investments was $11000.0 for Q4 2023 at Vera Therapeutics, down from $13000.0 in the prior quarter.
- Across five years, Long-Term Investments topped out at $1.5 million in Q2 2021 and bottomed at $11000.0 in Q4 2023.
- A 3-year average of $423000.0 and a median of $122000.0 in 2022 frame the typical range for Long-Term Investments.
- Peak annual rise in Long-Term Investments reached 78.08% in 2022, while the deepest fall reached 93.31% in 2022.
- Vera Therapeutics' Long-Term Investments stood at $867000.0 in 2021, then plunged by 93.31% to $58000.0 in 2022, then tumbled by 81.03% to $11000.0 in 2023.
- Business Quant data shows VERA's Long-Term Investments at $11000.0 in Q4 2023, $13000.0 in Q3 2023, and $29000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 505,194.89 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 5.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 9.79 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 58,000.00 |
| Sep 30, 2022 | 122,000.00 |
| Jun 30, 2022 | 324,000.00 |
| Mar 31, 2022 | 580,000.00 |
| Dec 31, 2021 | 867,000.00 |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.48 Mn |